Sec. 562.013. APPLICABILITY OF SUBCHAPTER. Unless a drug is determined to be generically equivalent to, or a biological product is determined to be interchangeable with, the brand prescribed, drug or biological product selection as authorized by this subchapter does not apply to:
(1) an enteric-coated tablet;
(2) a controlled release product;
(3) an injectable suspension, other than an antibiotic;
(4) a suppository containing active ingredients for which systemic absorption is necessary for therapeutic activity; or
(5) a different delivery system for aerosol or nebulizer drugs.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 12, eff. September 1, 2015.
Structure Texas Statutes
Subtitle J - Pharmacy and Pharmacists
Chapter 562 - Practice by License Holder
Subchapter A. Prescription and Substitution Requirements
Section 562.002. Legislative Intent
Section 562.003. Disclosure of Price; Patient's Option
Section 562.004. Prescription Transmitted Orally by Practitioner
Section 562.005. Record of Dispensed Drug or Biological Product
Section 562.0051. Communication Regarding Certain Dispensed Biological Products
Section 562.0061. Other Prescription Information
Section 562.0062. Required Statement Regarding Medication Disposal
Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized
Section 562.012. Substitution of Dosage Form Permitted
Section 562.013. Applicability of Subchapter
Section 562.014. Narrow Therapeutic Index Drugs
Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited
Section 562.0142. Adoption of Rules
Section 562.015. Dispensing Directive; Compliance With Federal Law
Section 562.016. List of Approved Interchangeable Biological Products